US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

162.65

+0.14500.09%

Volume:4.55M

Turnover:737.85M

Market Cap:11.53B

PE:8.92

High:163.24

Open:161.60

Low:161.16

Close:162.50

52wk High:169.89

52wk Low:91.10

Shares:70.90M

Float Shares:70.90M

Volume Ratio:0.97

T/O Rate:6.41%

Dividend:0.57

Dividend Rate:0.35%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ramsay Health Care Announces Retirement of Non-Executive Director

Revenue Beat: Shanghai Henlius Biotech, Inc. Exceeded Revenue Forecasts By 5.4% And Analysts Are Updating Their Estimates

Simply Wall St.

Anlon Healthcare Revises AGM Notice After Exchange Observations on Preferential Share Issue

Health Care up as Biotech Momentum Persists

Vital Healthcare Property Trust Sets Q4 DRP Strike Price at Discount

Health Care Roundup: Market Talk

Will Legend Biotech’s (LEGN) Move to Q2 Profitability Reshape Its Investment Narrative?

Simply Wall St.

Molecular Partners: Pipeline Momentum and Early Safety Data Support Unchanged $12 Price Target and Buy Rating

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live

VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase

Sagimet Reiterated as Buy on De-Risked Acne Program and Clearer Regulatory Path; $29 Price Target Maintained

Decent Holding Provides Operational Update: Community Healthcare Network Expands to 623 Centers and Over 210,000 Paid Members

Analysts’ Top Healthcare Picks: Dyne Therapeutics (DYN), Universal Health (UHS)

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live

Touyun Biotech to Raise HK$15 Million via Discounted Share Subscription

YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute

Incannex Begins Phase 2 DReAMzz Trial for IHL-42X

Kane Biotech’s revyve Wound Care Technology Draws Military Research Interest

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Rhythm Pharmaceuticals (RYTM)

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/XBI/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":162.645,"timestamp":1788282923146,"preClose":162.5,"halted":0,"volume":4545649,"delay":0,"changeRate":0.0008923076923077552,"floatShares":70900000,"shares":70900000,"eps":18.23,"marketStatus":"Trading","change":0.145,"latestTime":"09-01 13:15:31 EDT","open":161.6,"high":163.24,"low":161.16,"amount":737850382.07086,"amplitude":0.0128,"askPrice":162.67,"askSize":37,"bidPrice":162.62,"bidSize":375,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":162.5,"sharesOutstanding":63325000,"nav":162.332292,"aum":11387610309.25,"dividendRate":0.003494,"bidAskSpread":0.000334,"preHourTrading":{"tag":"盘前","latestPrice":161.74,"preClose":162.5,"latestTime":"09:29 EDT","volume":32522,"amount":5238005.67836,"timestamp":1788269399999,"change":-0.76,"changeRate":-0.004677,"amplitude":0.012431},"postHourTrading":{"tag":"盘后","latestPrice":162.5,"preClose":162.5,"latestTime":"19:50 EDT","volume":82718,"amount":13426735.2877,"timestamp":1788220208580,"change":0,"changeRate":0,"amplitude":0.003746},"volumeRatio":0.968136,"impliedVol":0.3109,"impliedVolPercentile":0.5317},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":70900000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.968136,"shares":70900000,"dividePrice":0.5683,"high":163.24,"amplitude":0.0128,"preClose":162.5,"low":161.16,"week52Low":91.1,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":162.645,"committee":0.820388,"eps":18.23,"divideRate":0.003494,"volume":4545649,"delay":0,"ttmEps":18.23,"open":161.6,"prevYearClose":121.93,"prevWeekClose":162.38,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":169.1,"twentyDayClose":151.88,"sixtyDayClose":128.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662750780","title":"Ramsay Health Care Announces Retirement of Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750780","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662750780?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:38","pubTimestamp":1787697487,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) has shared an update. Ramsay Health Care has announced that Non-Executive Director Dr Claudia Süssmuth Dyckerhoff ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-announces-retirement-of-non-executive-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-announces-retirement-of-non-executive-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4585","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662636587","title":"Revenue Beat: Shanghai Henlius Biotech, Inc. Exceeded Revenue Forecasts By 5.4% And Analysts Are Updating Their Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2662636587","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662636587?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:13","pubTimestamp":1787696023,"startTime":"0","endTime":"0","summary":"As you might know, Shanghai Henlius Biotech, Inc. ( HKG:2696 ) recently reported its interim numbers. It was a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/revenue-beat-shanghai-henlius-biotech-inc-exceeded-revenue-f","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/revenue-beat-shanghai-henlius-biotech-inc-exceeded-revenue-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662980757","title":"Anlon Healthcare Revises AGM Notice After Exchange Observations on Preferential Share Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2662980757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662980757?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:33","pubTimestamp":1787693622,"startTime":"0","endTime":"0","summary":"Anlon Healthcare Limited ( ($IN:AHCL) ) has provided an update. Anlon Healthcare Limited has issued a corrigendum to its notice for the 13th Annual...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anlon-healthcare-revises-agm-notice-after-exchange-observations-on-preferential-share-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anlon-healthcare-revises-agm-notice-after-exchange-observations-on-preferential-share-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGM","BK4229","LU0128526141.USD","BK4585","BK4137","BK4195","LABU","BK4581","LU0029874061.USD","BK4588","XLV","XBI","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662527027","title":"Health Care up as Biotech Momentum Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=2662527027","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662527027?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:04","pubTimestamp":1787691840,"startTime":"0","endTime":"0","summary":"Health-care companies rose as the biotech sub-sector gathered momentum.Moderna shares rose by more than 9%, and were headed for their largest monthly gain on record, due to enthusiasm about its cancer vaccine.Jazz Pharmaceuticals shares rose after the Food and Drug Administration approved the drug maker's product candidate, Ziihera, to treat a form of stomach cancer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4581","XLV","BK4585","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752227","title":"Vital Healthcare Property Trust Sets Q4 DRP Strike Price at Discount","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752227","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752227?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:54","pubTimestamp":1787691265,"startTime":"0","endTime":"0","summary":"Vital Healthcare Property ( ($NZ:VHP) ) just unveiled an update. Vital Healthcare Property Trust has set the strike price for its distribution rein...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-sets-q4-drp-strike-price-at-discount?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-sets-q4-drp-strike-price-at-discount?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4581","XLV","BK4588","BK8073","XBI","BK8059","BK4585","VHP.NZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662127752","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2662127752","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662127752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:50","pubTimestamp":1787691000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1259 ET - Moderna's finding that the mRNA-based vaccine it made ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588","XLV","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662663757","title":"Will Legend Biotech’s (LEGN) Move to Q2 Profitability Reshape Its Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662663757","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662663757?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:31","pubTimestamp":1787689883,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation recently reported its second-quarter 2026 results, with revenue rising to US$387.5 million from US$255.1 million and net income turning to US$33.2 million from a net loss of US$125.4 million a year earlier.\nOver the first half of 2026, revenue increased to US$692.6 million while the company sharply reduced its net loss to US$21.1 million, highlighting a rapid improvement in profitability metrics.\nWith Legend Biotech’s latest quarter showing a shift to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/will-legend-biotechs-legn-move-to-q2-profitability-reshape-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/will-legend-biotechs-legn-move-to-q2-profitability-reshape-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARTY","AIPO","BK4505","BK4588","BK4581","CANC","BK4139","XBI","LEGN","MEDI","VTHR","MEMS","QTOC","BK4585","AGIX","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662754039","title":"Molecular Partners: Pipeline Momentum and Early Safety Data Support Unchanged $12 Price Target and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2662754039","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662754039?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:15","pubTimestamp":1787688918,"startTime":"0","endTime":"0","summary":"Molecular Partners, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Charles Zhu from LifeSci Capital maintaine...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/molecular-partners-pipeline-momentum-and-early-safety-data-support-unchanged-12-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/molecular-partners-pipeline-momentum-and-early-safety-data-support-unchanged-12-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4588","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662975932","title":"Exchange-Traded Funds Rise as US Equities Advance After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662975932","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662975932?lang=en_us&edition=fundamental","pubTime":"2026-08-26 01:18","pubTimestamp":1787678281,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV were higher. Actively traded Invesco QQQ Trust (QQQ) added 0.6%.US equity indexes rose as technology topped sector charts while go","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLD","FAZ","FDVV","VIS","BTF","QQQM","SOXX","IYK","STCE","XLF","XLI","XRT","IGM","IYH","SLV","VHT","XDTE","XLE","BITO","BETH","BETE","VHT.AU",".DJI","FDN","STT","XLP","XLV","UNG","VOO","VDC","XSD","XLY","DGRO","RTH","IYJ",".IXIC","XBI","ETH","ARKY","USO",".SPX","IBB","EETH","IYW","IYE","FAS","XLK","MGK","QQQ","RTH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662530737","title":"VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 23:00","pubTimestamp":1787670008,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 25th, 2026, FinanceWire Following completion of the initial phase of its collaboration with OmniAb, VERAXA wil...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-vxa-222-cancer-program-beyond-discovery-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-vxa-222-cancer-program-beyond-discovery-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNQmain","IYW","QID","QQQE","FTEC","QDTE","BK4588","SQQQ","TQQQ","PSQ","ONEQ","NQmain",".IXIC","QLD","NVIW.SI","VRXA","NDX","JEPQ","QQQJ","QQQM","TECS","QQQ","BK4581","BK4585","GPIQ","TQQY","QQQA","XBI","QQQY","QYLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662753708","title":"Sagimet Reiterated as Buy on De-Risked Acne Program and Clearer Regulatory Path; $29 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2662753708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662753708?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:45","pubTimestamp":1787669128,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Brandon Folkes from H.C. Wa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sagimet-reiterated-as-buy-on-de-risked-acne-program-and-clearer-regulatory-path-29-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sagimet-reiterated-as-buy-on-de-risked-acne-program-and-clearer-regulatory-path-29-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4139","BK4588","BK4585","XBI","LABU","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662580757","title":"Decent Holding Provides Operational Update: Community Healthcare Network Expands to 623 Centers and Over 210,000 Paid Members","url":"https://stock-news.laohu8.com/highlight/detail?id=2662580757","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662580757?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:30","pubTimestamp":1787664600,"startTime":"0","endTime":"0","summary":"YANTAI, China, Aug.  25, 2026 (GLOBE NEWSWIRE) -- Decent Holding Inc. (NASDAQ: DXST) (“Decent” or the “Company”), a technology-driven provider of wastewater treatment and community-based senior health","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350564/0/en/decent-holding-provides-operational-update-community-healthcare-network-expands-to-623-centers-and-over-210-000-paid-members.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","XBI","BK4550","CN","KBWY","VHT","BK4588","LABU","NOBL","DXST","BK4225","BK4203","TCAF","CHCT","BK4120","IXJ","CGCV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662737038","title":"Analysts’ Top Healthcare Picks: Dyne Therapeutics (DYN), Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662737038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662737038?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:20","pubTimestamp":1787664011,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dyne Therapeutics (DYN) and Universal Health (UHS) w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dyne-therapeutics-dyn-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dyne-therapeutics-dyn-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","UHS","BK4585","HCSG","BK4588","BK4185","LU0029874061.USD","XBI","LABU","LU0128526141.USD","BK4581","BK4137","DYN","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662423737","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662423737","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662423737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:15","pubTimestamp":1787663703,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF  slightly advancing and the iShares Biotechnology ETF  up 0.2%.Immatics  shares were up more than 13% after the company said it has agreed to sell about 12.9 million ordinary shares at $8.69 each, and in lieu of ordinary shares to certain investors, pre-funded warrants to buy up to approximately 4.3 million ordinary shares at $8.689 per pre-funded warrant.Veeva Systems  has signed Biogen  and Regeneron Pharmaceuticals  as new users for its Veeva Vault CRM platform, according to statements from Veeva. Shares of Veeva Systems were down 0.1% premarket.Bausch + Lomb  stock was up more than 1% after the company said it plans to advance two of its pharmaceutical pipeline assets to new trials based on latest clinical results.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z9P08.USD","BLCO","LU0058720904.USD","LU1974910355.USD","BK4532","BK4588","LU0114720955.EUR","LU2362541273.HKD","LU0109394709.USD","LU2468319806.SGD","BK4613","BK4139","LU2089984988.USD","LU1917777945.USD","LU0823434740.USD","LU0029874061.USD","PBE","LU0889565916.HKD","VEEV","XLV","BK4504","EKG","TBXU","LU2362540622.SGD","LU0170899867.USD","IBB","IMTX","LU0320765992.SGD","BK4533","BK4581","IBBQ","BK4198","LU0128526141.USD","BK4534","BMED","LU0234570918.USD","LU2237438978.USD","XBI","BIIB","BBH","LU0882574055.USD","LU2023250504.SGD","LU0053666078.USD","LABU","LU0289739699.SGD","HCSG","REGN","LGHT","BK4528","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662329917","title":"Touyun Biotech to Raise HK$15 Million via Discounted Share Subscription","url":"https://stock-news.laohu8.com/highlight/detail?id=2662329917","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662329917?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:40","pubTimestamp":1787661624,"startTime":"0","endTime":"0","summary":"China Touyun Tech Group ( ($HK:1332) ) has shared an announcement. Touyun Biotech Group Limited has entered into an agreement with a subscriber to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/touyun-biotech-to-raise-hk15-million-via-discounted-share-subscription?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/touyun-biotech-to-raise-hk15-million-via-discounted-share-subscription?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662684732","title":"YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2662684732","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662684732?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659200,"startTime":"0","endTime":"0","summary":"TAIPEI, Taiwan, Aug.  25, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and op","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350403/0/en/yd-bio-announces-peer-reviewed-publication-in-nutrients-co-authored-with-physicians-from-the-taiwan-chronic-disease-healthcare-association-and-the-future-health-institute.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XBI","HCSG","BK4585","XLV","LABU","BK4581","BK4137","LU0029874061.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662348617","title":"Incannex Begins Phase 2 DReAMzz Trial for IHL-42X","url":"https://stock-news.laohu8.com/highlight/detail?id=2662348617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662348617?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:55","pubTimestamp":1787658920,"startTime":"0","endTime":"0","summary":"Incannex Healthcare Limited Sponsored ADR ( ($IXHL) ) has shared an update. On August 25, 2026, Incannex Healthcare announced that the first patien...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/incannex-begins-phase-2-dreamzz-trial-for-ihl-42x?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/incannex-begins-phase-2-dreamzz-trial-for-ihl-42x?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","SAPH","BK4588","LABU","APIE","ARMH","XLV","BK4581","BK4585","DIVL","AADR","DINT","CVY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731620","title":"Kane Biotech’s revyve Wound Care Technology Draws Military Research Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731620","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662731620?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:41","pubTimestamp":1787658092,"startTime":"0","endTime":"0","summary":"Kane Biotech ( ($TSE:KNE) ) has issued an update. Kane Biotech announced that research on its revyve Antimicrobial Wound Gel Spray was presented at...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kane-biotechs-revyve-wound-care-technology-draws-military-research-interest?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kane-biotechs-revyve-wound-care-technology-draws-military-research-interest?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736083","title":"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Rhythm Pharmaceuticals (RYTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736083","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662736083?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:50","pubTimestamp":1787655028,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Monte Rosa Therapeutics (GLUE) and Rhythm Pharmaceut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-and-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-and-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XLV","BK4588","RYTM","BK4581","XBI","BK4139","LABU","MEDI","BK4585","LU0029874061.USD","BK4539","GLUE","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273574","title":"Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273574","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273574?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:40","pubTimestamp":1787654408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GE Healthcare Technologies Inc (GEHC), Biogen (BIIB)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","PPA","LU1551013425.SGD","XAR","LU0689626769.HKD","BK4082","LU0109394709.USD","LU0889565916.HKD","DFEN","LU2168564222.USD","TRUI","LU0077335932.USD","XBI","LU0354030511.USD","LU1280957306.USD","NATO","BK4588","MDCO","LU0353189763.USD","ONC","MISL","LU2543165471.USD","LABU","LU2168564065.EUR","BK4581","IE00B19Z9P08.USD","LU2264538146.SGD","GE","LU2756315664.SGD","LU0689472784.USD","PBE","EXI","BIIB","LU0354030438.USD","LU0868494617.USD","XLV","IE00B894F039.SGD","BK4187","LU0943347566.SGD","LU1366192091.USD","LU1988902786.USD","BK4139","UXI","ITA","BK4526","LGHT","GEHC","BK4543","LU1551013342.USD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":9,"totalSize":347,"code":"91000000","status":"200"}]}}